Alcon - Registered Shares Overview
Valuation check: ALC's ROE is 3.66%, below the Healthcare sector average of 29.33%.
Get informed when a big investor buys or sells
+ Follow3.66%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for ALC is 3.66%. That is below the Healthcare sector average of 29.33%. Investors often review this figure alongside Alcon - Registered Shares's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, ALC currently prints 3.66% for ROE, while the sector average sits near 29.33%. That is roughly 87.5% below the sector mean. Large gaps often invite a closer look at Alcon - Registered Shares's growth, margins, and balance sheet.
Return on Equity shows how effectively Alcon - Registered Shares converts resources into returns. At 3.66%, ALC may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ALC's ROE (3.66%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Alcon - Registered Shares's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
